CRYSTAL FORM OF ABEMACICLIB MESYLATE, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL COMPOSITION THEREOF

Disclosed is a crystal form of abemaciclib mesylate, which has one or more improved properties compared with the known abemaciclib mesylate. Also involved are a method for preparing the crystal form of abemaciclib mesylate, a pharmaceutical composition and the use of same in the preparation of a dru...

Full description

Saved in:
Bibliographic Details
Main Authors SHENG, Xiaohong, SHENG, Xiaoxia
Format Patent
LanguageEnglish
Published 17.06.2021
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

Abstract Disclosed is a crystal form of abemaciclib mesylate, which has one or more improved properties compared with the known abemaciclib mesylate. Also involved are a method for preparing the crystal form of abemaciclib mesylate, a pharmaceutical composition and the use of same in the preparation of a drug for treating cancer diseases such as colorectal cancer, breast cancer, lung cancer, prostate cancer, glioblastoma, mantle cell lymphoma, chronic granulocytic leukemia and acute granulocytic leukemia.
AbstractList Disclosed is a crystal form of abemaciclib mesylate, which has one or more improved properties compared with the known abemaciclib mesylate. Also involved are a method for preparing the crystal form of abemaciclib mesylate, a pharmaceutical composition and the use of same in the preparation of a drug for treating cancer diseases such as colorectal cancer, breast cancer, lung cancer, prostate cancer, glioblastoma, mantle cell lymphoma, chronic granulocytic leukemia and acute granulocytic leukemia.
Author SHENG, Xiaoxia
SHENG, Xiaohong
Author_xml – fullname: SHENG, Xiaohong
– fullname: SHENG, Xiaoxia
BookMark eNqNjL0KwjAURjvo4N87XHBVsEpRx9v0hgSaJiTp0KkUiThIW6jvj6H4AE4fHM751smiH_qwSl7MNs5jCVxbBZoD5qSQSVbKHBS5pkRPBzCWDFr0UleReqEL8IIsxQqwKsAItDGj2ksWz5hWRjs567On-TZZPrv3FHa_3SR7Tp6JYxiHNkxj9wh9-LS1O5_OaXq9Z7cM08t_1hdkYTiE
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2021179585A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2021179585A13
IEDL.DBID EVB
IngestDate Fri Jul 19 15:23:11 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2021179585A13
Notes Application Number: US201817048384
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210617&DB=EPODOC&CC=US&NR=2021179585A1
ParticipantIDs epo_espacenet_US2021179585A1
PublicationCentury 2000
PublicationDate 20210617
PublicationDateYYYYMMDD 2021-06-17
PublicationDate_xml – month: 06
  year: 2021
  text: 20210617
  day: 17
PublicationDecade 2020
PublicationYear 2021
RelatedCompanies Hangzhou SoliPharma Co., Ltd
RelatedCompanies_xml – name: Hangzhou SoliPharma Co., Ltd
Score 3.3349311
Snippet Disclosed is a crystal form of abemaciclib mesylate, which has one or more improved properties compared with the known abemaciclib mesylate. Also involved are...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Title CRYSTAL FORM OF ABEMACICLIB MESYLATE, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL COMPOSITION THEREOF
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210617&DB=EPODOC&locale=&CC=US&NR=2021179585A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1NT8IwtCFq1Juixg80TTQ7uQisMDgQ03VdhmF02YeBE6GjRBMziMz4932roJy49eO1aV_6-j77itCD1W5NJSFds6usmUmyVtOUWTY36yoDAUFlSkqd7XPY9lPyMmqNKuhj8xZG5wn91skRgaIyoPdC39fLfyOWq2MrV0_yHZoWz17Sc421dtwsFRzbcJ0eD4UrmMFYL42NYaT74OyBcExBV9oHQdou6YG_OuW7lOU2U_FO0EEI8-XFKaqovIqO2ObvtSo6DNYubyiuqW91ht5YNI4TOsCguQVYeJg6PKCszwZ9Bwc8Hg9owh8xIDWkv7YnaE184eLE5xGHUZgOXRz6NIJhPE3KXAiYiSAUcV-DazjhnaN7jyfMN2HJkz8MTdJ4e3_WBdrLF7m6RHguVZt05rbs1iVR02ZHzkq_IQHYRmY1yBWq7Zrpenf3DTouq2XkVMOuob3i80vdAo8u5J1G7Q92cI0P
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dT8IwsCFoxDdFjR-oTTR7chFYYfBAzNZ12XRf2YeBJ0JHiSYGiMz4971VUJ54a-6ul_bSa-_auytC91q3M-GE9NW-0KYqyTttlef5TG2KHAwEkQvOZbXPoOtk5HnYGVbQxyYXRtYJ_ZbFEUGjctD3Qu7Xy_9LLEvGVq4e-TuAFk92OrCUtXfcLh0cXbHMAYtCK6QKpYMsUYJY4mDtgXFsgK-0B0a2XuoDezXLvJTl9qFiH6H9CPjNi2NUEfM6qtHN32t1dOCvn7yhuda-1Ql6o_EoSQ0Pg-fm49DGhsl8g7rUc03ss2TkGSl7wCDUyPi9ewJo6oQWTh0WM-iFjcDCkWPE0I1laVkLAdPQj8LEleSSLrRP0Z3NUuqoMOTxn4TGWbI9P-0MVeeLuThHeMZFl_RmOu83ORGTdo9Py3dDArStXGuRC9TYxelyN_oW1ZzU98aeG7xcocMSVUZRtfQGqhafX-IazuuC30gx_wBBKpAC
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=CRYSTAL+FORM+OF+ABEMACICLIB+MESYLATE%2C+PREPARATION+METHOD+THEREFOR+AND+PHARMACEUTICAL+COMPOSITION+THEREOF&rft.inventor=SHENG%2C+Xiaohong&rft.inventor=SHENG%2C+Xiaoxia&rft.date=2021-06-17&rft.externalDBID=A1&rft.externalDocID=US2021179585A1